$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2017-11-09 AccNo: 0001193125-17-338019 Size: 102 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接